$GUER
Guerrilla RF Inc Stock $guer

$guer Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000143774922026860 Filed on November 10, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$2.428M	$2.219M	$0.00
YoY Change	-76.83%
Cost Of Revenue	$1.060M	$950.8K	$945.9K
YoY Change	-75.58%	0.52%
Gross Profit	$1.369M	$1.268M	$1.221M
YoY Change	-77.71%	3.92%
Gross Profit Margin	56.36%	57.16%
Selling, General & Admin	$2.496M	$2.518M	$14.65K
YoY Change	-51.74%	17085.45%
% of Gross Profit	182.38%	198.48%	1.2%
Research & Development	$2.198M	$2.097M	$1.061M
YoY Change	-52.14%	97.73%
% of Gross Profit	160.61%	165.34%	86.9%
Depreciation & Amortization	$456.9K	$373.0K
YoY Change	23.02%
% of Gross Profit	33.39%	29.41%
Operating Expenses	$4.694M	$4.615M	$14.65K
YoY Change	-51.93%	31401.33%
Operating Profit	-$3.326M	-$3.346M	-$1.176M
YoY Change	-8.26%	184.51%
Interest Expense	-$443.3K	-$303.4K	-$160.1K
YoY Change	-19.62%	89.45%
% of Operating Profit
Other Income/Expense, Net	$17.75K	-$321.4K	$673.2K
YoY Change	-98.72%	-147.74%
Pretax Income	-$3.751M	-$3.668M	-$14.65K
YoY Change	34.33%	24936.72%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.751M	-$3.700M	-$14.65K
YoY Change	34.33%	25155.97%
Net Earnings / Revenue	-154.48%	-166.72%
Basic Earnings Per Share		-$0.11	-$0.07
Diluted Earnings Per Share	-$0.11	-$0.11	-$2.930K
COMMON SHARES
Basic Shares Outstanding	33.72M	33.71M	6.794M
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.340M	$2.055M	$7.390K
YoY Change	-18.32%	27706.36%
Cash & Equivalents	$4.340M	$2.055M	$7.390K
Short-Term Investments
Other Short-Term Assets	$643.4K	$376.9K
YoY Change	-45.82%
Inventory	$1.673M	$1.752M
Prepaid Expenses	$643.4K	$376.9K
Receivables	$1.125M	$913.9K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$7.782M	$5.098M	$7.390K
YoY Change	-19.0%	68881.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.098M	$8.144M
YoY Change	396.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.575M
YoY Change
Total Long-Term Assets	$8.883M	$8.362M	$0.00
YoY Change	764.64%
TOTAL ASSETS
Total Short-Term Assets	$7.782M	$5.098M	$7.390K
Total Long-Term Assets	$8.883M	$8.362M	$0.00
Total Assets	$16.66M	$13.46M	$7.390K
YoY Change	56.7%	182039.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.466M	$2.562M	$4.500K
YoY Change	276.42%	56824.67%
Accrued Expenses	$139.8K	$121.6K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$959.8K	$0.00	$64.96K
YoY Change		-100.0%
Long-Term Debt Due	$1.079M	$1.103M
YoY Change	810.75%
Total Short-Term Liabilities	$6.644M	$4.004M	$69.46K
YoY Change	407.19%	5664.9%
LONG-TERM LIABILITIES
Long-Term Debt	$7.593M	$7.874M	$0.00
YoY Change	5144.72%
Other Long-Term Liabilities	$71.71K	$98.46K
YoY Change
Total Long-Term Liabilities	$7.665M	$7.973M	$0.00
YoY Change	5194.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.644M	$4.004M	$69.46K
Total Long-Term Liabilities	$7.665M	$7.973M	$0.00
Total Liabilities	$14.31M	$11.98M	$69.46K
YoY Change	732.37%	17143.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.10M	-$23.30M
YoY Change	80.11%
Common Stock	$3.727K	$3.338K
YoY Change	12.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.355M	$1.483M	-$62.07K
YoY Change
Total Liabilities & Shareholders Equity	$16.66M	$13.46M	$7.390K
YoY Change	56.7%	182039.66%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$3.751M	-$3.700M	-$14.65K
YoY Change	34.33%	25155.97%
Depreciation, Depletion And Amortization	$456.9K	$373.0K
YoY Change	23.02%
Cash From Operating Activities	-$3.268M	-$1.783M	-$13.15K
YoY Change	-31.56%	13458.78%
INVESTING ACTIVITIES
Capital Expenditures	-$1.040M	$1.290M
YoY Change	164.43%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$1.040M	-$1.290M
YoY Change	-364.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.513M	3.424M	9.980K
YoY Change	-55.12%	34204.21%
NET CHANGE
Cash From Operating Activities	-3.268M	-1.783M	-13.15K
Cash From Investing Activities	1.040M	-1.290M
Cash From Financing Activities	4.513M	3.424M	9.980K
Net Change In Cash	2.286M	350.2K	-3.170K
YoY Change	-53.25%	-11146.06%
FREE CASH FLOW
Cash From Operating Activities	-$3.268M	-$1.783M	-$13.15K
Capital Expenditures	-$1.040M	$1.290M
Free Cash Flow	-$2.228M	-$3.073M
YoY Change	-49.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33384894
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33384894
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33222192
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33222192
CY2022Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	636434	usd
CY2022Q3	guer	Finance Lease Liability Remainder Of Fiscal Year FinanceLeaseLiabilityRemainderOfFiscalYear	270443	usd
CY2022Q3	guer	Finance Lease Liability Year One FinanceLeaseLiabilityYearOne	1109308	usd
CY2022Q3	guer	Finance Lease Liability Year Two FinanceLeaseLiabilityYearTwo	1159675	usd
CY2022Q3	guer	Finance Lease Liability Year Three FinanceLeaseLiabilityYearThree	907665	usd
CY2022Q3	guer	Finance Lease Liability Year Four FinanceLeaseLiabilityYearFour	874192	usd
CY2022Q3	guer	Finance Lease Liability After Year Four FinanceLeaseLiabilityAfterYearFour	114310	usd
CY2022Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	4435593	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	33122	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	133814	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2021Q4	us-gaap	Transfer Of Financial Assets Accounted For As Sales Fair Value Of Derecognized Assets TransferOfFinancialAssetsAccountedForAsSalesFairValueOfDerecognizedAssets	0	usd
CY2022Q3	guer	Accounts Receivable Secured Debt Facility Receivables Assigned AccountsReceivableSecuredDebtFacilityReceivablesAssigned	300000	usd
CY2022Q3	guer	Accounts Receivable Secured Debt Facility Amount Due AccountsReceivableSecuredDebtFacilityAmountDue	300000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	guer	Sharebased Payment Arrangement Granted Award Cost Not Yet Recognized Period For Recognition SharebasedPaymentArrangementGrantedAwardCostNotYetRecognizedPeriodForRecognition	P2Y3M18D
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2600000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	300000	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	343287	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1356013	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1331709	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1009002	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	915244	usd
CY2022Q3	guer	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	116772	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	5072027	usd
CY2022Q3	guer	Finance Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year FinanceLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear	72844	usd
CY2022Q3	guer	Finance Lease Liability Undiscounted Excess Amount Next Twelve Months FinanceLeaseLiabilityUndiscountedExcessAmountNextTwelveMonths	246705	usd
CY2022Q3	guer	Finance Lease Liability Undiscounted Excess Amount Year Two FinanceLeaseLiabilityUndiscountedExcessAmountYearTwo	172034	usd
CY2022Q3	guer	Finance Lease Liability Undiscounted Excess Amount Year Three FinanceLeaseLiabilityUndiscountedExcessAmountYearThree	101337	usd
CY2022Q3	guer	Finance Lease Liability Undiscounted Excess Amount Year Four FinanceLeaseLiabilityUndiscountedExcessAmountYearFour	41052	usd
CY2022Q3	guer	Finance Lease Liability Undiscounted Excess Amount After Year Four FinanceLeaseLiabilityUndiscountedExcessAmountAfterYearFour	2462	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	67570	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	234506	usd
CY2022Q3	guer	Operating Lease Liability Remainder Of Fiscal Year OperatingLeaseLiabilityRemainderOfFiscalYear	29443	usd
CY2022Q3	guer	Operating Lease Liability Year One OperatingLeaseLiabilityYearOne	124389	usd
CY2022Q3	guer	Operating Lease Liability Year Two OperatingLeaseLiabilityYearTwo	66212	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	220044	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56238
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3837067
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1196 Pleasant Ridge Road, Suite 5
	dei	Entity Address City Or Town EntityAddressCityOrTown	Greensboro
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27409
	dei	City Area Code CityAreaCode	336
	dei	Local Phone Number LocalPhoneNumber	510-7840
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33716474
CY2022Q3	us-gaap	Cash Cash	2054888	usd
CY2021Q4	us-gaap	Cash Cash	5313985	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	913859	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1667006	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	1752078	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1439014	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	376892	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1187418	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	5097717	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9607423	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	218340	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	8144064	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1027312	usd
CY2022Q3	us-gaap	Assets Assets	13460121	usd
CY2021Q4	us-gaap	Assets Assets	10634735	usd
CY2022Q3	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	217998	usd
CY2021Q4	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	5117	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	121584	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1103105	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	118420	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2561611	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1186443	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4004298	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1309980	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	98460	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3332488	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	264347	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	4541892	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	144783	usd
CY2022Q3	us-gaap	Liabilities Liabilities	11977138	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1719110	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	3338	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3322	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24801627	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23958705	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23321982	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15046402	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1482983	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8915625	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13460121	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10634735	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2219304	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2166570	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9172565	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7745012	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	950841	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	945926	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3775881	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3138736	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1268463	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	1220644	usd
	us-gaap	Gross Profit GrossProfit	5396684	usd
	us-gaap	Gross Profit GrossProfit	4606276	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2097276	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1060691	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5916216	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3184329	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1192286	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	657311	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3447564	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1883032	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1325383	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	678853	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3828763	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1361808	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4614945	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2396855	usd
	us-gaap	Operating Expenses OperatingExpenses	13192543	usd
	us-gaap	Operating Expenses OperatingExpenses	6429169	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3346482	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1176211	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7795859	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1822893	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-303368	usd
CY2021Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-160130	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-431442	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-469783	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-18028	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	833300	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-48279	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1369100	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-321396	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	673170	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-479721	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	899317	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3667878	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-503041	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8275580	usd
	us-gaap	Net Income Loss NetIncomeLoss	-923576	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8915625	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1866090	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5232	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	32856	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7087623	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2741612	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	181302	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4527313	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3667878	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	470384	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	153164	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1482983	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3125294	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	130235	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12667	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6352	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-2976040	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-550770	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	22927	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6352	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-3497531	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-503041	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1402	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2528	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-3996642	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8275580	usd
	us-gaap	Net Income Loss NetIncomeLoss	-923576	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	900637	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	262868	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	367322	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15232	usd
	us-gaap	Accretion Expense AccretionExpense	16910	usd
	us-gaap	Accretion Expense AccretionExpense	0	usd
	guer	Amortization Of Warrants AmortizationOfWarrants	0	usd
	guer	Amortization Of Warrants AmortizationOfWarrants	18625	usd
	guer	Gain Loss On Ppp Loan Forgiveness GainLossOnPPPLoanForgiveness	-0	usd
	guer	Gain Loss On Ppp Loan Forgiveness GainLossOnPPPLoanForgiveness	1369100	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-753147	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-376206	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	313064	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	289690	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-810526	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	232536	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-240321	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	109913	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5980423	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2032058	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1590027	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	294282	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1590027	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-294282	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5232	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	36996	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	7213761	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	6479400	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	470384	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans		usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	2640686	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	4971046	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	737338	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	76005	usd
	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	usd
	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	833300	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4311353	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2302645	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3259097	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-23695	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5313985	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	427269	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2054888	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	403574	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	4811873	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	114519	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1615489	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	48500	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><em style="font: inherit;">1.</em> ORGANIZATION AND NATURE OF BUSINESS</b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">All references in this Quarterly Report to “Guerrilla RF” refer to Guerrilla RF Operating Corporation, our direct, wholly-owned subsidiary. Unless otherwise stated or the context otherwise indicates, references to the “Company”, “we”, “our”, “us” or similar terms refer to Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp.) together with its wholly-owned subsidiary, Guerrilla RF. Guerrilla RF holds all material assets and conducts all business activities and operations of the Company. Accordingly, there are frequent references to Guerrilla RF throughout this Quarterly Report.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF, Inc. was incorporated in the State of Delaware on <em style="font: inherit;"> November 9, 2020. </em>On <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021,</em> the Company's wholly-owned subsidiary, Guerrilla RF Acquisition Corp., a corporation formed in the State of Delaware on <em style="font: inherit;"> October </em><em style="font: inherit;">20,</em> <em style="font: inherit;">2021</em> (“Acquisition Sub”) and privately held Guerrilla RF Operating Corporation (formerly known as Guerrilla RF, Inc.) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, on <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021</em> (the “Closing Date”), Acquisition Sub merged with and into Guerrilla RF Operating Corporation with Guerrilla RF Operating Corporation continuing as the surviving corporation and a wholly-owned subsidiary of the Company (the “Merger”). </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Prior to the Merger, Laffin Acquisition Corp. was a “shell” company registered under the Securities Exchange Act of <em style="font: inherit;">1934,</em> as amended (the "Exchange Act"), with <em style="font: inherit;">no</em> specific business plan or purpose until it began operating the business of Guerrilla RF Operating Corporation following the closing of the Merger.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF designs high‐performance Monolithic Microwave Integrated Circuits (MMICs) for the wireless infrastructure market. Guerrilla RF primarily focuses on researching and developing its existing and future products and building an infrastructure to handle a global distribution network; therefore, it has incurred significant start‐up losses. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Merger was accounted for as a “reverse acquisition” since, immediately following the consummation of the Merger, Guerrilla RF effectively controlled the Company. For accounting purposes, Guerrilla RF was deemed the accounting acquirer in the Merger. Consequently, the Merger is treated as a recapitalization of Guerrilla RF (i.e., a capital transaction involving the issuance of shares by the Company for the shares of Guerrilla RF). Accordingly, the assets, liabilities, and results of operations of Guerrilla RF became the historical consolidated financial statements of the Company, and the Company’s assets, liabilities, and results of operations were consolidated with Guerrilla RF beginning at the Closing Date. <em style="font: inherit;">No</em> step-up in basis or intangible assets or goodwill were recorded in the Merger.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Liquidity and Going Concern</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In accordance with Financial Accounting Standards (“FASB”) Accounting Standards Update (“ASU”) <em style="font: inherit;">No.</em> <em style="font: inherit;">2014</em>-<em style="font: inherit;">15,</em> <i>Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic <em style="font: inherit;">205</em>-<em style="font: inherit;">40</em>)</i>, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within <em style="font: inherit;">one</em> year after the date that the unaudited interim condensed consolidated financial statements are issued. The accompanying unaudited interim condensed consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the ordinary course of business. The Company has historically financed its activities principally from common and preferred equity securities and debt issuances.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">The Company has incurred recurring losses, and negative cash flows from operations in nearly every fiscal period since its inception, including a </span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">net loss of $3.7 million for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2022</em></span></span><span style="background-color:#ffffff;">. In addition, as of <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2022,</em> the Company had an accumulated deficit o</span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">f $23.3 million</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">.</span></span><span style="background-color:#ffffff;"> The Company expects losses and negative cash flows to continue, primarily as a result of continued investment in research and development, capital additions supporting our planned business expansion and growth, and sales and marketing efforts. The Company had a cash balance of $2.1 million at <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2022.</em> In <em style="font: inherit;"> June 2022, </em>the Company established a new loan facility with Spectrum Commercial Services Company, L.L.C. ("Spectrum") providing for advances of up to $3.0 million (the "Spectrum Loan Facility" further described in Note <em style="font: inherit;">5</em>). As of <em style="font: inherit;"> September 30, 2022, </em>the outstanding balance under the Spectrum Loan Facility was $0.2 million. In <em style="font: inherit;"> August </em><em style="font: inherit;">2022,</em> the Company established a new loan facility with Salem Investment Partners V, Limited Partnership ("Salem") providing for advances of up to $8.0 million (the "Salem Loan Facility" further described in Note <em style="font: inherit;">5</em>). As of <em style="font: inherit;"> September 30, 2022, </em>the undiscounted outstanding balance under the Salem Loan Facility was $5.0 million.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Company is actively pursuing additional financing to support its current and future liquidity needs, including an equity capital raise of up to <em style="font: inherit;">$10</em> million. The Company believes that its cash and funding availability under its <em style="font: inherit;">two</em> loan facilities will provide sufficient resources to support operations through the middle of <em style="font: inherit;"> December 2022. </em>In the event the Company does <em style="font: inherit;">not</em> successfully close the equity capital raise on a timely basis the Company will request that Salem release some or all of the remaining <em class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="font: inherit;">$3.0</em> million provided for under the Salem Loan Facility. There is <em style="font: inherit;">no</em> assurance that the pending equity capital raise will successfully close on a timely basis, or at all. Nor is there any assurance that Salem will consent to the Company drawing down some or all of the <em class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="font: inherit;">$3.0</em> million additional loan facility. If the Company is unsuccessful in securing sufficient additional funding before the middle of <em style="font: inherit;"> December 2022, </em>it will be unable to fund ongoing operations and pay its obligations as they become due. This requirement for additional funding raises substantial doubt about our ability to continue as a going concern. The unaudited interim condensed consolidated financial statements do <em style="font: inherit;">not</em> include any adjustments relating to the recoverability of the recorded assets or the classification of liabilities that <em style="font: inherit;"> may </em>be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"/> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Risks and Uncertainties</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company is subject to several risks associated with companies at a similar stage, including dependence on key individuals, competition from similar products and larger companies, volatility of the industry, ability to obtain adequate financing to support growth, the ability to attract and retain additional qualified personnel to manage the anticipated growth of the Company, and general economic conditions.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> December 2019, </em>a novel strain of coronavirus disease (“COVID-<em style="font: inherit;">19”</em>) was reported, and in <em style="font: inherit;"> March 2020, </em>the World Health Organization characterized COVID-<em style="font: inherit;">19</em> as a global pandemic. The COVID-<em style="font: inherit;">19</em> pandemic has forced international, federal, state, and local governments to enforce prohibitions of non-essential activities. The Company <em style="font: inherit;">first</em> saw the impact of COVID-<em style="font: inherit;">19</em> in the <em style="font: inherit;">first</em> quarter of <em style="font: inherit;">2020.</em> The extent and duration of the adverse impact of COVID-<em style="font: inherit;">19</em> on the Company over the longer term remains uncertain and dependent on future developments that cannot be accurately predicted at this time, such as the severity and transmission rate of COVID-<em style="font: inherit;">19</em> and its related variants, the extent and effectiveness of containment actions taken, including mobility restrictions, the timing, availability, and effectiveness of vaccines, and the impact of these and other factors on travel behavior in general and on the Company’s business.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As the impact of COVID-<em style="font: inherit;">19</em> continues to evolve, estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions <em style="font: inherit;"> may </em>change in future periods and will be recognized in the condensed consolidated financial statements as new events occur, and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future condensed consolidated financial statements could be affected.</p>
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3700000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23300000	usd
CY2022Q3	us-gaap	Cash Cash	2100000	usd
CY2022Q3	us-gaap	Transfer Of Financial Assets Accounted For As Sales Fair Value Of Derecognized Assets TransferOfFinancialAssetsAccountedForAsSalesFairValueOfDerecognizedAssets	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 0pt; text-align: justify;"><b>Use of Estimates</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of our condensed consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and related disclosures. Additionally, the business and economic uncertainty resulting from the COVID-<em style="font: inherit;">19</em> pandemic and the Russia-Ukraine conflict has made such estimates and assumptions more difficult to calculate. The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements, and reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments involve the identification of performance obligations in revenue recognition, the valuation of share-based compensation, and the valuation of share-based financing, including the underlying fair value of the common stock. Accordingly, actual results could differ from those estimates.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p>
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	12794	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	1752078	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1439014	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.53
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y1M2D
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Concentrations of Credit Risk and Major Customers</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Financial instruments at <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2022</em> and <em style="font: inherit;">2021</em> that potentially subject the Company to concentration of credit risk consist primarily of cash and accounts receivable.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s cash is deposited with major financial institutions in the U.S. At times, deposits in financial institutions located in the U.S. <em style="font: inherit;"> may </em>be in excess of the amount of insurance provided on such deposits by the Federal Deposit Insurance Corporation. To date, the Company has <em style="font: inherit;">not</em> experienced any losses on its cash deposits.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s accounts receivable are derived from revenue earned from customers located in and outside of the U.S. Major customers are defined as those generating revenue in excess of <em style="font: inherit;">10%</em> of the Company’s aggregate annual revenue. The Company had <span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;">one </span>major distributor customer, Richardson RFPD, Inc. ("RFPD") <span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;">accounti</span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">ng for </span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">81% o</span><span style="background-color:#ffffff;">f product shipment revenue</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> for the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2022</em> and <em style="font: inherit;">2021.</em> Accounts receivable from RFPD represented <span style="-sec-ix-hidden:c91108343">84</span></span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">% and 94% of accounts receivable</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> at <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2022</em> and <em style="font: inherit;">2</em></span></span><span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;">021,</em> respectively. </span></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p>
CY2022Q3	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
	guer	Factoring Agreement Receivables Term Oustanding FactoringAgreementReceivablesTermOustanding	P90D
CY2022Q3	guer	Factoring Agreement Percentage Of Receivables Collateral FactoringAgreementPercentageOfReceivablesCollateral	0.15	pure
CY2022Q2	guer	Proceeds From Accounts Receivable Factoring ProceedsFromAccountsReceivableFactoring	3000000	usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M26D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	93500
CY2022Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3938898
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6229146
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0011	pure
	us-gaap	Advertising Expense AdvertisingExpense	36302	usd
	us-gaap	Advertising Expense AdvertisingExpense	15107	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33260160
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6761771
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33316416
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6794216
CY2022Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	750575	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	629090	usd
CY2022Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	32204	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	339746	usd
CY2022Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	969299	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	482972	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	-0	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10623188	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2605800	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2479124	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1578488	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8144064	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1027312	usd
	us-gaap	Depreciation Depreciation	900000	usd
	us-gaap	Depreciation Depreciation	300000	usd
CY2022Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	18000	usd
CY2022Q3	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
CY2022Q3	guer	Factoring Agreement Factoring Fee First Thirty Days Percentage Of Invoice Face Value FactoringAgreementFactoringFeeFirstThirtyDaysPercentageOfInvoiceFaceValue	0.0098	pure
CY2022Q3	guer	Factoring Agreement Factoring Fee After Thirty Days Percentage Of Invoice Face Value FactoringAgreementFactoringFeeAfterThirtyDaysPercentageOfInvoiceFaceValue	0.000327	pure
CY2022Q3	guer	Factoring Agreement Minimum Invoice Fee FactoringAgreementMinimumInvoiceFee	1.50	usd
CY2022Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0011	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0379	pure
	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	0	usd
	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	75661	usd
CY2021Q3	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	24050	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	217998	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2022Q3	guer	Longterm Debt Maturity After Year Four LongtermDebtMaturityAfterYearFour	4541892	usd
CY2022Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	4759890	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.66
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	32862
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3607318
CY2022Q3	guer	Common Stock Voting Rights Vote Per Share CommonStockVotingRightsVotePerShare	1	pure
	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	568000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1260000
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.70
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	1.57
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.67	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.67	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0379	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.40
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.23
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	538812	usd
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	74731	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3180882
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.38
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y3M18D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	130000
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.00
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12702
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.41
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3298180
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.44
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M19D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	248500
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.00
CY2022Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3546680
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.55
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2806565
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.35
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y5M15D
CY2021Q4	guer	Factor Of Change In Exercise Price Of Options FactorOfChangeInExercisePriceOfOptions	2.95	pure
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3700000	usd
CY2022Q3	guer	Sharebased Payment Arrangement Granted Award Option Cost Not Yet Recognized Amount SharebasedPaymentArrangementGrantedAwardOptionCostNotYetRecognizedAmount	500000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	367300	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15200	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2600000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	300000	usd
CY2022Q3	guer	Lessee Operating Lease Lease Not Yet Commenced Annual Lease Expense LesseeOperatingLeaseLeaseNotYetCommencedAnnualLeaseExpense	1100000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	218340	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	121584	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	98460	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	220044	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4600405	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1103105	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3332488	usd
CY2022Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	4435593	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	99772	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	98068	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	615102	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	56069	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	163107	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	13613	usd
	guer	Finance Lease Cost FinanceLeaseCost	778209	usd
	guer	Finance Lease Cost FinanceLeaseCost	69682	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M
CY2022Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M3D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0700	pure
CY2022Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0698	pure
	us-gaap	Operating Lease Payments OperatingLeasePayments	98068	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	163107	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	737338	usd
CY2022Q3	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear	3679	usd
CY2022Q3	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year One LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearOne	9425	usd
CY2022Q3	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Two LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearTwo	1358	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14462	usd
CY2022Q3	guer	Lessee Operating Lease Lease Not Yet Commenced Building Asset Additions LesseeOperatingLeaseLeaseNotYetCommencedBuildingAssetAdditions	4000000.0	usd
CY2022Q3	guer	Severance Pay Obligation Percentage SeverancePayObligationPercentage	1	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	120000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2588000	usd
CY2022Q1	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04	pure
CY2022Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	93728	usd
CY2021Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	58780	usd

Files In Submission

Name	View Source	Status
0001437749-22-026860-index-headers.html	Edgar Link	pending
0001437749-22-026860-index.html	Edgar Link	pending
0001437749-22-026860.txt	Edgar Link	pending
0001437749-22-026860-xbrl.zip	Edgar Link	pending
ex_413941.htm	Edgar Link	pending
ex_413942.htm	Edgar Link	pending
ex_413943.htm	Edgar Link	pending
ex_413944.htm	Edgar Link	pending
ex_425368.htm	Edgar Link	pending
ex_425651.htm	Edgar Link	pending
ex_425657.htm	Edgar Link	pending
ex_425658.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
guer-20220930.xsd	Edgar Link	pending
guer20220816_10q.htm	Edgar Link	pending
image01.jpg	Edgar Link	pending
image02.jpg	Edgar Link	pending
image03.jpg	Edgar Link	pending
image04.jpg	Edgar Link	pending
image05.jpg	Edgar Link	pending
image06.jpg	Edgar Link	pending
image07.jpg	Edgar Link	pending
image08.jpg	Edgar Link	pending
image09.jpg	Edgar Link	pending
image10.jpg	Edgar Link	pending
image11.jpg	Edgar Link	pending
image12.jpg	Edgar Link	pending
image13.jpg	Edgar Link	pending
image14.jpg	Edgar Link	pending
image15.jpg	Edgar Link	pending
image16.jpg	Edgar Link	pending
image17.jpg	Edgar Link	pending
image18.jpg	Edgar Link	pending
image19.jpg	Edgar Link	pending
image20.jpg	Edgar Link	pending
image21.jpg	Edgar Link	pending
image22.jpg	Edgar Link	pending
image23.jpg	Edgar Link	pending
image24.jpg	Edgar Link	pending
image25.jpg	Edgar Link	pending
image26.jpg	Edgar Link	pending
image27.jpg	Edgar Link	pending
image28.jpg	Edgar Link	pending
image29.jpg	Edgar Link	pending
image30.jpg	Edgar Link	pending
image31.jpg	Edgar Link	pending
image32.jpg	Edgar Link	pending
image33.jpg	Edgar Link	pending
image34.jpg	Edgar Link	pending
image35.jpg	Edgar Link	pending
image36.jpg	Edgar Link	pending
image37.jpg	Edgar Link	pending
image38.jpg	Edgar Link	pending
image39.jpg	Edgar Link	pending
image40.jpg	Edgar Link	pending
image41.jpg	Edgar Link	pending
image42.jpg	Edgar Link	pending
image43.jpg	Edgar Link	pending
image44.jpg	Edgar Link	pending
image45.jpg	Edgar Link	pending
guer-20220930_cal.xml	Edgar Link	unprocessable
guer-20220930_def.xml	Edgar Link	unprocessable
guer-20220930_lab.xml	Edgar Link	unprocessable
guer-20220930_pre.xml	Edgar Link	unprocessable
guer20220816_10q_htm.xml	Edgar Link	completed
image46.jpg	Edgar Link	pending
image47.jpg	Edgar Link	pending
image48.jpg	Edgar Link	pending
image49.jpg	Edgar Link	pending
image50.jpg	Edgar Link	pending
image51.jpg	Edgar Link	pending
image52.jpg	Edgar Link	pending
image53.jpg	Edgar Link	pending
image54.jpg	Edgar Link	pending
image55.jpg	Edgar Link	pending
image56.jpg	Edgar Link	pending
image57.jpg	Edgar Link	pending
image58.jpg	Edgar Link	pending
image59.jpg	Edgar Link	pending
image60.jpg	Edgar Link	pending
image61.jpg	Edgar Link	pending
image62.jpg	Edgar Link	pending
image63.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GUER
Guerrilla RF Inc Stock $guer

2022 Q4 Form 10-Q Financial Statement

#000143774922026860 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER Guerrilla RF Inc Stock $guer

2022 Q4 Form 10-Q Financial Statement

#000143774922026860 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER
Guerrilla RF Inc Stock $guer